Press releases

January 17, 2017

PharmaFluidics raises 2.7 million euro to commercialize novel micro-chip device for Biomarker, Diagnostics and Drug development applications

Ghent, Belgium - January 17, 2017 - PharmaFluidics NV, a game-changing innovator in the field of analytical chromatography, announced today that it has raised 2.7 million euro of additional funding.
January 11, 2018

PharmaFluidics raises 7.3 million euro to expand commercialization of novel micro-chip device for biomarker, diagnostics and drug development applications

Ghent, Belgium – January 11, 2018 – PharmaFluidics NV, a game-changing innovator in the field of analytical chromatography, announced today that it has raised 7.3 million euro. The company will focus on intensifying international growth, supported by initial, promising sales.
October 1, 2018
PharmaFluidics Facilitates Ultra-high-resolution Proteomics Analysis Through Agreement with Thermo Fisher Scientific

PharmaFluidics Facilitates Ultra-high-resolution Proteomics Analysis Through Agreement with Thermo Fisher Scientific

Ghent, Belgium – September 30, 2018 – PharmaFluidics NV, an innovative bio-analytical chromatography company, announced today that it entered into a Partnership Agreement with Thermo Fisher Scientific Inc, a global Life Sciences Tools and Instruments leader. The agreement empowers PharmaFluidics to sell Thermo Fisher custom-made EASY-Spray™ transfer lines, in combo sets with PharmaFluidics’ own line of µPAC™ chromatography micro-Chips, to constitute an ultra-high-resolution front-end source platform for Thermo Fisher mass spectrometry (MS) instruments.